DI BELLO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 9.979
AS - Asia 5.339
EU - Europa 3.820
AF - Africa 847
SA - Sud America 815
OC - Oceania 96
Continente sconosciuto - Info sul continente non disponibili 64
Totale 20.960
Nazione #
US - Stati Uniti d'America 9.511
SG - Singapore 1.799
IT - Italia 1.299
CN - Cina 867
VN - Vietnam 793
HK - Hong Kong 588
BR - Brasile 493
FR - Francia 416
FI - Finlandia 328
DE - Germania 285
UA - Ucraina 262
SE - Svezia 161
PL - Polonia 145
IN - India 135
BD - Bangladesh 115
NL - Olanda 109
IQ - Iraq 96
RU - Federazione Russa 91
GB - Regno Unito 90
TR - Turchia 78
AR - Argentina 63
PK - Pakistan 62
SA - Arabia Saudita 59
PH - Filippine 57
EC - Ecuador 54
CA - Canada 50
ID - Indonesia 46
JP - Giappone 42
MX - Messico 42
UZ - Uzbekistan 41
JO - Giordania 40
TN - Tunisia 40
ZA - Sudafrica 38
UY - Uruguay 37
CO - Colombia 36
CZ - Repubblica Ceca 34
AE - Emirati Arabi Uniti 33
AO - Angola 33
CH - Svizzera 32
LV - Lettonia 32
KE - Kenya 31
MA - Marocco 31
MY - Malesia 30
EG - Egitto 29
IR - Iran 29
TH - Thailandia 29
ES - Italia 28
IE - Irlanda 28
JM - Giamaica 28
LU - Lussemburgo 28
PT - Portogallo 28
DZ - Algeria 27
NI - Nicaragua 27
CL - Cile 26
DO - Repubblica Dominicana 26
ET - Etiopia 26
RO - Romania 26
BE - Belgio 25
GA - Gabon 25
KH - Cambogia 25
KR - Corea 25
ME - Montenegro 25
NP - Nepal 25
AM - Armenia 24
CG - Congo 24
GT - Guatemala 24
KG - Kirghizistan 24
MR - Mauritania 24
YE - Yemen 24
AT - Austria 23
BB - Barbados 23
CR - Costa Rica 23
HN - Honduras 23
MD - Moldavia 23
MK - Macedonia 23
SI - Slovenia 23
AD - Andorra 22
BF - Burkina Faso 22
CI - Costa d'Avorio 22
GF - Guiana Francese 22
GM - Gambi 22
LB - Libano 22
PS - Palestinian Territory 22
PY - Paraguay 22
TZ - Tanzania 22
ZM - Zambia 22
ZW - Zimbabwe 22
BO - Bolivia 21
BS - Bahamas 21
GR - Grecia 21
NZ - Nuova Zelanda 21
PA - Panama 21
PR - Porto Rico 21
VE - Venezuela 21
XK - ???statistics.table.value.countryCode.XK??? 21
AL - Albania 20
AU - Australia 20
MG - Madagascar 20
MN - Mongolia 20
NO - Norvegia 20
Totale 19.974
Città #
Singapore 1.045
Jacksonville 990
San Jose 952
Woodbridge 924
Ann Arbor 668
Fairfield 658
Chandler 607
Ashburn 605
Hong Kong 535
Houston 486
Wilmington 316
Ho Chi Minh City 249
Princeton 240
Seattle 222
Boardman 215
Santa Clara 214
Cambridge 184
Hanoi 164
Helsinki 159
Beijing 152
Los Angeles 141
Lauterbourg 130
Bytom 100
Medford 98
Padova 96
Dong Ket 91
Nanjing 81
Rome 79
San Diego 72
Roxbury 64
Guangzhou 63
Milan 61
Des Moines 53
São Paulo 47
Council Bluffs 45
Da Nang 45
New York 44
Buffalo 42
The Dalles 40
Naples 39
Amman 35
Hebei 35
Baghdad 34
Tashkent 33
Dallas 32
Montevideo 32
Luanda 29
Redwood City 29
Norwalk 28
Chicago 26
Managua 26
Padua 26
Palermo 26
Riga 26
Warsaw 26
Dublin 25
Florence 25
Podgorica 25
Shenyang 25
Tianjin 25
Tokyo 25
Nairobi 24
Nanchang 24
Istanbul 23
Shanghai 23
Andorra la Vella 22
Jeddah 22
Jiaxing 22
Libreville 22
Lusaka 22
Bridgetown 21
Nassau 21
Abidjan 20
Bishkek 20
Dar es Salaam 20
Harare 20
Nouakchott 20
Phnom Penh 20
Ulan Bator 20
Yerevan 20
Brooklyn 19
Haiphong 19
Kingston 19
Lahore 19
Tunis 19
Addis Ababa 18
Antananarivo 18
Kampala 18
Niamey 18
Noumea 18
Ouagadougou 18
Panama City 18
Quito 18
Atlanta 17
Biên Hòa 17
Bologna 17
Castries 17
Guatemala City 17
Johannesburg 17
Munich 17
Totale 12.373
Nome #
Biomateriali. Dalla scienza dei materiali alle applicazioni cliniche 1.216
Interazioni tra biomateriali e tessuti 310
Automation of the liquid-phase synthesis of biopolymers 231
Surface treatments and roughness properties of Ti-based biomaterials 225
In vitro and in vivo pro-angiogenic effects of thymosin-beta4-derived peptides 225
Adhesion and spreading of human osteoblasts on biomimetic glass surfaces evaluated by Total Internal Reflection Fluorescence (TIRF) microscopy 221
Peptidi della vitronectina e loro impiego terapeutico nella adesione degli osteoblasti 218
The proprotein convertase SKI-1/S1P - In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors 217
Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides 214
Covalent surface modification of titanium oxide with different adhesive peptides: surface characterization and osteoblast-like cell adhesion. 207
Assessment of novel chemical strategies for covalent attachment of adhesive peptides to rough titanium surfaces: XPS analysis and biological evaluation 206
Improvement of Anselme's adhesion model for evaluating human osteoblast response to peptide-grafted titanium surfaces 205
Effect of synthetic peptides on osteoblast adhesion 199
A novel Algorithm for the Coupling Control in Solid Phase Peptide Synthesis 195
Self-assembling peptides: A combined XPS and NEXAFS investigation on the structure of two dipeptides Ala-Glu, Ala-Lys 193
Novel osteoblast-adhesive peptides for dental/orthopedic biomaterials 191
Peptides adsorption on TiO2 and Au: molecular organization investigated by NEXAFS, XPS and IR 181
Evaluation of human osteoblast-like cell adhesion strength on Ti substrates functionalized by bioactive peptide grafting 181
Thin films of a self-assembling peptide on TiO2 and Au studied by NEXAFS, XPS and IR spectroscopies 179
SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENHANCE HIV-1 INFECTION THROUGH A CD4-DEPENDENT MECHANISM 178
BINDING TO CD4 OF SYNTHETIC PEPTIDES PATTERNED ON THE PRINCIPAL NEUTRALIZING DOMAIN OF THE HIV-1 ENVELOPE PROTEIN 177
A method for the final yield prediction and for the automatic control of solid-phase peptide synthesis 177
CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation 175
Heparin enhances the furin cleavage of HIV-1 gp160 peptides 174
AFFINITY-CHROMATOGRAPHY OF CD4 LIGANDS 173
Conformational analysis of heparin binding peptides 172
Anti-HIV-activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1 170
Anti-HIV-1 activity of CD4 synthetic oligopeptides representative of the putative gp120 binding site 170
Synthetic Peptides Derived from the Angiostatin K4 Domain Inhibit Endothelial Cell Migration 168
MINIMAL SEQUENCE REQUIREMENTS FOR SYNTHETIC PEPTIDES DERIVED FROM THE V3 LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO ENHANCE HIV-1 BINDING TO CELLS AND INFECTION 168
A batch-type system for the large-scale solid-phase oligonucleotide synthesis 167
SPPS of Difficult Sequences: a Comparison of Chemical Conditions, Synthetic Strategies and On-line Monitoring 164
Self-assembling peptides: correlation among sequence, secondary structure in solution and film formation 164
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 163
Structural studies on model peptides reproducing the processing site of the ocytocin/neurophysin precursor 161
Automated biopolymer synthesis 159
SPPS of difficult sequences: a comparison of chemical conditions, synthetic strategies and on-line monitoring 157
The structure of synthetic peptides from the Principal Neutralizing Domain of HIV-1 gp120 affects binding to CD4 and viral infectivity 156
Fermentation diagnosis by multivariate statistical analysis 156
Design, synthesis and CD4 binding studies of a fluorescent analogue of a peptide that enhances HIV-1 infectivity 155
Studi con marcatori di fotoaffinità  confermano il binding tra sCD4 e il PND di HIV-1 MN 154
STRUCTURAL STUDIES ON SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HIV-1 GP120 THAT BIND TO CD4 AND ENHANCE HIV-1 INFECTION 153
Synthetic Peptides Derived from the Principal Neutralizing Domain Modulate HIV-1 Infection 153
EVIDENCE FOR THE PRESENCE OF A SECONDARY STRUCTURE AT THE DIBASIC PROCESSING SITE OF PROHORMONE - THE PRO-OXYTOCIN MODEL 152
Structural investigation and kinetic characterization of potential cleavage sites of HIV gp160 by human Furin and PC1 150
Conformation and bioactive properties of novel osteoblast-adhesive peptides for biomaterial design 146
Conformational study of self-assembling peptides 145
Biological and Confornational Studies on Analogues of a Synthetic Peptide Enhancing HIV-1 Infection 145
Anti HIV-1 Activities of CD4 Synthetic Oligopeptides 144
Application of statistical process control to solid-phase synthesis of peptides 143
In vitro and in vivo evaluation of SiO2-based coating enriched with a bioactive peptide 143
Coupling control in solid-phase peptide synthesis and on-line monitoring 142
Large-scale automated biopolymers synthesis 142
Semi-automatic detection of the reaction between hemocyanin and oxygen 141
Investigations Using Photo Affinity Labeled Analogues Confirm the Binding between sCD4 and the PND of HIV-1, MN 141
Is the V3 loop involved in HIV binding to CD4? 141
Mining genomic expression data 139
Peptidi sintetici atti a potenziare l'infettività del virus HIV-1 139
A Type-II-b Turn, Proline-Containing, Cyclic Pentapeptide as a Building Block for the Construction of Models of the Cleavage Site of Pro-ocytocin 139
In-line monitoring of the key reactions in automated solid-phase peptide synthesis 139
Synthetic peptides suitable to enhance HIV-1 virus infectivity 138
Synthesis, characterization and conformational analysis of gp120-derived synthetic peptides that specifically enhance HIV-1 infectivity 138
Conformational studies on synthetic peptides reproducing the dibasic processing site of pro-ocytocin-neurophysin 138
Evaluation of osteoblast adhesion on biomimetic Ti surfaces: comparison among different strategies for the immobilization of peptides 138
Apparatus and process for the liquid phase oligonucleotide synthesis 137
Extracting dynamic patterns from gene expression data by the analysis of an autoassociative neural network architecture 136
Novel Immobilization of an adhesion peptide on the TiO2 surface: an XPS investigation 135
Furin-mediated Cleavage of Natural and Modified gp160 Peptides 134
Synthetic peptides for study of human immunodeficiency virus infection 134
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: Role of site-specific mutations 134
Processo di maturazione della glicoproteina gp160: analisi conformazionale e studi cinetici su peptidi riproducenti il sito di clivaggio enzimatico di gp160 133
A novel prototype for automated synthesis of peptides 133
Evidence for the Presence of a Secondary Binding Site Between HIV-MN-gp120 PND and the CD4 CDR3 Region 131
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site. solution conformation of a 41-MER peptide 131
An improved system for automated peptides synthesis 131
Design And Evaluation Of Sol-gel Peptide-enriched Dressing For Improving Osteoblast Adhesion To Ti Surfaces 128
Synthetic peptides derived from the PND of HIV-1 enhance virus infection: role of charged and aromatic amino acids in determining biological and conformational properties 128
Peptidi Sintetici Derivati dal V3 Loop di HIV-1 Modulano l'Infezione virale 127
Funzionalizzazione di superfici mediante peptidi 126
The use of synthetic peptides in the study of HIV-1/target cell interactions 125
Morphological characterization of Ti and Ti6Al4V surfaces after mechanical and chemical treatments: a rational approach to the design of implantable devices 125
The structure of synthetic peptides from the Principal Neutralizing Domain of gp120 affects binding to CD4 and viral infectivity 124
Peptidi Sintetici Appartenenti al Dominio Principale di Neutralizzazione di gp120 Modulano l'Infettività del Virus HIV-1 124
Introduzione di un doppio vincolo conformazionale in un peptide del PND che aumenta l'infettività  del virus HIV-1 per lo studio delle relazioni struttura-funzione 124
Studio dei Fattori che Determinano in Vitro l'Effetto Attivante Dose-Dipendente e Non Virus-Ristretto di Peptidi del PND 123
Automated liquid-phase biopolymers synthesis 123
Biomateriali e segnali molecolari 121
Synthetic Peptides Derived From the Principal Neutralizing Domain (PND) of Human Immunodeficiency Virus Type 1 (HIV-1) Enhance HIV-1 Infection 121
Structural Investigation of the HIV-1 Envelope Glycoprotein gp160 Cleavage Site, 2: Relevance of an N-Terminal Helix 121
Automation of Peptide Synthesis Amino Acids, Peptides and Proteins in Organic Chemistry 120
Synthetic peptides suitable to enhance HIV-1 virus infectivity 120
Anti-HIV activity of peptides derived from the C-terminal sequence of SDF-1b 119
Dental implant osseo-integration: a coupled biochemical and biomechanical approach 119
Synthetic Peptides Mapped on Angiostatin K4 Domain Inhibit Endothelial Cell Migration 117
A conformational study on anti-HIV C-terminal SDF-1 derived peptides 114
Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding 113
Development of a prototype for the automated solid-phase synthesis of peptides 111
Thin films of a self-assembling peptide on TiO2 and Au studied by NEXAFS, XPS and IR spectroscopies 111
Effects of synthetic peptides on adhesion of osteoblasts cultured in vitro: a preliminary study 110
The structure of synthetic peptides from the Principal Neutralizing Domain of gp120 affects binding to CD4 and viral infectivity 110
Totale 16.434
Categoria #
all - tutte 58.301
article - articoli 26.312
book - libri 2.700
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 2.738
selected - selezionate 0
volume - volumi 6.973
Totale 97.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.207 0 256 107 54 48 70 33 112 66 20 168 273
2022/20231.395 325 124 12 168 231 185 8 81 161 24 51 25
2023/2024777 36 78 54 59 41 39 42 49 81 46 161 91
2024/20252.790 81 181 181 97 474 42 102 242 223 96 449 622
2025/20268.918 256 848 1.278 1.168 801 376 1.125 957 1.064 532 356 157
2026/2027396 290 106 0 0 0 0 0 0 0 0 0 0
Totale 20.960